EGFR and skin squamous cell carcinoma: While cytotoxic chemotherapy and EGFR inhibitors have been historically used to treat cSCC, neither of these approaches achieves durable disease control, and the role of these agents in the PD-1 failed setting, in particular, remains unclear.